10-Q Filing

NOVO INTEGRATED SCIENCES, INC. CIK: 1138978 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0001493152-19-000456`
Period End Date	20181130
Filing Date	20190111
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	nvos-20181130.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 40 Cash Flow Statement 48

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$929.14K	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$675.71K	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.41M	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.34M	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other receivables, current portion	`OtherReceivablesNetCurrent`	$393.82K	USD	Point-in-time
Other receivables, current portion	`OtherReceivablesNetCurrent`	$357.53K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$149.15K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	499.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	499.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$161.84K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	207.88M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	208.44M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.57M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.84M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$400.32K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	208.44M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	207.88M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$445.03K	USD	Point-in-time
Other receivables, net of current portion	`LongTermInvestmentsAndReceivablesNet`	$86.56K	USD	Point-in-time
Other receivables, net of current portion	`LongTermInvestmentsAndReceivablesNet`	$57.35K	USD	Point-in-time
Acquisition deposits	`DepositsAssetsNoncurrent`	$1.09M	USD	Point-in-time
Acquisition deposits	`DepositsAssetsNoncurrent`	$1.11M	USD	Point-in-time
Goodwill	`Goodwill`	$594.63K	USD	Point-in-time
Goodwill	`Goodwill`	$604.11K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$4.74M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$5.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.37M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.31M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$384.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$362.76K	USD	Point-in-time
Accrued interest (principally to related parties)	`InterestPayableCurrent`	$156.12K	USD	Point-in-time
Accrued interest (principally to related parties)	`InterestPayableCurrent`	$167.66K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$1.06M	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$1.12M	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$376.35K	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$382.35K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.34M	USD	Point-in-time
Debentures, related parties	`SecuredLongTermDebt`	$1.22M	USD	Point-in-time
Debentures, related parties	`SecuredLongTermDebt`	$1.20M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$4.54M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$4.57M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at November 30, 2018 and August 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Convertible preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at November 30, 2018 and August 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.001 par value; 499,000,000 shares authorized; 208,444,965 and 207,881,743 shares issued and outstanding at November 30, 2018 and August 31, 2018	`CommonStockValue`	$208.44K	USD	Point-in-time
Common stock; $0.001 par value; 499,000,000 shares authorized; 208,444,965 and 207,881,743 shares issued and outstanding at November 30, 2018 and August 31, 2018	`CommonStockValue`	$207.88K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$10.66M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$10.05M	USD	Point-in-time
Other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.14M	USD	Point-in-time
Other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.14M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.20M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.45M	USD	Point-in-time
Total Novo Integrated Sciences, Inc. stockholders' equity	`StockholdersEquity`	$201.39K	USD	Point-in-time
Total Novo Integrated Sciences, Inc. stockholders' equity	`StockholdersEquity`	$550.97K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-33.26K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-28.62K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$172.77K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$517.71K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$5.06M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$4.74M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.31M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.25M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$1.41M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$1.43M	USD	1 Quarter
Gross profit	`GrossProfit`	$846.04K	USD	1 Quarter
Gross profit	`GrossProfit`	$883.54K	USD	1 Quarter
Selling expenses	`SellingExpense`	$25.22K	USD	1 Quarter
Selling expenses	`SellingExpense`	$38.14K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$980.27K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.07M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.10M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.02M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-215.35K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-172.37K	USD	1 Quarter
Interest income	`OtherNonoperatingIncome`	$51.00	USD	1 Quarter
Interest income	`OtherNonoperatingIncome`	$5.09K	USD	1 Quarter
Interest expense	`OtherNonoperatingExpense`	$46.32K	USD	1 Quarter
Interest expense	`OtherNonoperatingExpense`	$134.15K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-134.10K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-41.23K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-256.58K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-306.47K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$54.22K	USD	1 Quarter
Net loss	`ProfitLoss`	$-256.58K	USD	1 Quarter
Net loss	`ProfitLoss`	$-360.69K	USD	1 Quarter
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.40K	USD	1 Quarter
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-5.17K	USD	1 Quarter
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-251.42K	USD	1 Quarter
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-357.29K	USD	1 Quarter
Net loss	`ProfitLoss`	$-256.58K	USD	1 Quarter
Net loss	`ProfitLoss`	$-360.69K	USD	1 Quarter
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$124.19K	USD	1 Quarter
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-101.03K	USD	1 Quarter
Comprehensive loss:	`ComprehensiveIncomeNetOfTax`	$-236.50K	USD	1 Quarter
Comprehensive loss:	`ComprehensiveIncomeNetOfTax`	$-357.61K	USD	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	207.94M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	201.84M	shares	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-256.58K	USD	1 Quarter
Net loss	`ProfitLoss`	$-360.69K	USD	1 Quarter
Depreciation	`Depreciation`	$22.60K	USD	1 Quarter
Depreciation	`Depreciation`	$15.00K	USD	1 Quarter
Fair value of vested stock options	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1`	$70.85K	USD	1 Quarter
Fair value of vested stock options	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1`	$142.66K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$197.39K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$90.15K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-10.35K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-54.79K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$81.22K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-82.70K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-15.45K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$29.41K	USD	1 Quarter
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$14.21K	USD	1 Quarter
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$47.10K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-351.81K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-162.96K	USD	1 Quarter
Purchase of furniture and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$74.41K	USD	1 Quarter
Purchase of furniture and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.24K	USD	1 Quarter
Amounts loaned for other receivables	`PaymentsForProceedsFromLoansReceivable`	$19.35K	USD	1 Quarter
Amounts loaned for other receivables	`PaymentsForProceedsFromLoansReceivable`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-74.41K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-23.59K	USD	1 Quarter
Repayments to related parties	`RepaymentsOfRelatedPartyDebt`	$176.80K	USD	1 Quarter
Repayments to related parties	`RepaymentsOfRelatedPartyDebt`	$34.55K	USD	1 Quarter
Proceeds from the sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$531.93K	USD	1 Quarter
Proceeds from the sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Payments on notes payable	`RepaymentsOfNotesPayable`	-	USD	1 Quarter
Payments on notes payable	`RepaymentsOfNotesPayable`	$7.12K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-183.93K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$497.38K	USD	1 Quarter
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-6.58K	USD	1 Quarter
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-41.61K	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$253.43K	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-600.94K	USD	1 Quarter
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.30M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.90M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$929.14K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$675.71K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.30M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.90M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$929.14K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$675.71K	USD	Point-in-time
Interest	`InterestPaidNet`	$99.76K	USD	1 Quarter
Interest	`InterestPaidNet`	$34.78K	USD	1 Quarter
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.